Envista (NVST) Projected to Post Earnings on Wednesday

Envista (NYSE:NVST) is anticipated to issue its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $0.31 per share and revenue of $680.0660 million for the quarter. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Parties may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Wednesday, May 6, 2026 at 5:00 PM ET.

Envista (NYSE:NVST) last announced its earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. The firm’s quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.24 EPS. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Envista Stock Performance

NVST traded down $0.25 during trading on Monday, hitting $26.08. The stock had a trading volume of 26,863 shares, compared to its average volume of 2,694,729. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. The firm has a market capitalization of $4.25 billion, a P/E ratio of 92.86, a PEG ratio of 1.80 and a beta of 0.92. The company’s 50-day moving average price is $26.73 and its 200 day moving average price is $23.93. Envista has a twelve month low of $16.29 and a twelve month high of $30.42.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Piper Sandler reissued a “neutral” rating and issued a $25.00 price objective (up from $21.00) on shares of Envista in a research note on Friday, February 6th. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Evercore set a $30.00 price objective on shares of Envista in a research note on Wednesday, April 8th. JPMorgan Chase & Co. boosted their price objective on shares of Envista from $22.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, February 6th. Finally, UBS Group boosted their price objective on shares of Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Tuesday, February 3rd. Six research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $28.25.

Insider Activity at Envista

In other Envista news, SVP Mischa Reis sold 9,675 shares of the business’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president directly owned 32,382 shares in the company, valued at approximately $971,460. The trade was a 23.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.99% of the company’s stock.

Institutional Investors Weigh In On Envista

Several institutional investors have recently made changes to their positions in NVST. Millennium Management LLC boosted its position in shares of Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after purchasing an additional 2,263,712 shares in the last quarter. Holocene Advisors LP purchased a new stake in shares of Envista during the 2nd quarter worth $43,936,000. Alliancebernstein L.P. boosted its position in shares of Envista by 34.0% during the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after purchasing an additional 1,547,656 shares in the last quarter. Freestone Grove Partners LP purchased a new stake in shares of Envista during the 4th quarter worth $29,046,000. Finally, Balyasny Asset Management L.P. purchased a new stake in shares of Envista during the 3rd quarter worth $24,260,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.